Single gene false positive and negative rates
| Gene | False negatives | Normal tissue false positives | Noncancerous breast disease tissue false positives | Total false positives |
| HES5 | 0/13 (0%) | 0/7 (0%) | 1/5 (20%) | 1/12 (8.3%) |
| HSP90AA1 | 2/11 (18.2%) | 0/6 (0%) | 2/5 (40%) | 2/11 (18.2%) |
| TGFB3 | 3/14 (21.4%) | 0/8 (0%) | 0/5 (0%) | 0/13 (0%) |
| MYC | 3/11 (27.3%) | 0/6 (0%) | 0/5 (0%) | 0/11 (0%) |
| ERBB2 | 4/14 (28.6%) | 1/9 (11.1%) | 3/5 (60%) | 4/14 (28.6%) |
| FOSL2 | 4/13 (30.8%) | 0/7 (0%) | 0/5 (0%) | 0/12 (0%) |
| CSF1R | 4/13 (30.8%) | 0/7 (0%) | 0/5 (0%) | 0/12 (0%) |
| AKT1 | 5/14 (35.7%) | 1/7 (14.3%) | 0/5 (0%) | 1/12 (8.3%) |
| Total | 25/103 (24.3%) | 2/57 (3.5%) | 6/40 (15.0%) | 8/97 (8.2%) |
| Gene | False negatives | Normal tissue false positives | Noncancerous breast disease tissue false positives | Total false positives |
| HES5 | 0/13 (0%) | 0/7 (0%) | 1/5 (20%) | 1/12 (8.3%) |
| HSP90AA1 | 2/11 (18.2%) | 0/6 (0%) | 2/5 (40%) | 2/11 (18.2%) |
| TGFB3 | 3/14 (21.4%) | 0/8 (0%) | 0/5 (0%) | 0/13 (0%) |
| MYC | 3/11 (27.3%) | 0/6 (0%) | 0/5 (0%) | 0/11 (0%) |
| ERBB2 | 4/14 (28.6%) | 1/9 (11.1%) | 3/5 (60%) | 4/14 (28.6%) |
| FOSL2 | 4/13 (30.8%) | 0/7 (0%) | 0/5 (0%) | 0/12 (0%) |
| CSF1R | 4/13 (30.8%) | 0/7 (0%) | 0/5 (0%) | 0/12 (0%) |
| AKT1 | 5/14 (35.7%) | 1/7 (14.3%) | 0/5 (0%) | 1/12 (8.3%) |
| Total | 25/103 (24.3%) | 2/57 (3.5%) | 6/40 (15.0%) | 8/97 (8.2%) |
The number (and percentages) of tissues that give either a false negative or false positive result. For a false negative, a gene has a similar RRD in a cancer tissue to that of the pooled normal distribution (two-sample 1D KS test, P > 0.01). A false positive is scored when a gene has a statistically different RRD than that of the pooled normal in noncancerous breast tissues (P < 0.01).